Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric J Moore

Showing results (221-230 of 239) with videos related to

Pageof 24
Sort By:
Oral Oncology|January 11, 2024
Association Between Social Determinants of Health, Distance from Treatment Center, and Treatment Type with Outcomes in Human Papillomavirus Associated Oropharyngeal cancerAisha A Aden, Felicia O Olawuni, Chadi N Abdel-Halim, et al.
International Journal of Radiation Oncology, Biology, Physics|August 30, 2017
Relapse Rates With Surgery Alone in Human Papillomavirus-Related Intermediate- and High-Risk Group Oropharynx Squamous Cell Cancer: A Multi-Institutional ReviewDavid M Routman, Ryan K Funk, Kanograt Tangsriwong, et al.
Thyroid : Official Journal of the American Thyroid Association|October 10, 2019
A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid CancerAshish V Chintakuntlawar, Jun Yin, Robert L Foote, et al.
Cancers|January 23, 2024
Mean Oral Cavity Organ-at-Risk Dose Predicts Opioid Use and Hospitalization during Radiotherapy for Patients with Head and Neck TumorsRobert L Foote, W Scott Harmsen, Adam C Amundson, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2022
Detectable Postoperative Circulating Tumor Human Papillomavirus DNA and Association with Recurrence in Patients With HPV-Associated Oropharyngeal Squamous Cell CarcinomaDavid M Routman, Sunil Kumar, Bisham S Chera, et al.
Plos One|February 23, 2010
Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterationsBrian B Tuch, Rebecca R Laborde, Xing Xu, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2020
Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ Cancer of the OropharynxMark R Waddle, Daniel J Ma, Sue L Visscher, et al.
Oral Oncology|September 17, 2023
Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated diseaseKathleen R Bartemes, Benjamin R Gochanour, David M Routman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2019
Reply to A.S. GardenDaniel J Ma, Katharine A Price, Eric J Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2019
Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus-Associated Oropharynx Squamous Cell CarcinomaDaniel J Ma, Katharine A Price, Eric J Moore, et al.
Pageof 24

Showing results (221-230 of 239) with videos related to

Sort By:
Pageof 24
Oral Oncology|January 11, 2024
Association Between Social Determinants of Health, Distance from Treatment Center, and Treatment Type with Outcomes in Human Papillomavirus Associated Oropharyngeal cancerAisha A Aden, Felicia O Olawuni, Chadi N Abdel-Halim, et al.
International Journal of Radiation Oncology, Biology, Physics|August 30, 2017
Relapse Rates With Surgery Alone in Human Papillomavirus-Related Intermediate- and High-Risk Group Oropharynx Squamous Cell Cancer: A Multi-Institutional ReviewDavid M Routman, Ryan K Funk, Kanograt Tangsriwong, et al.
Thyroid : Official Journal of the American Thyroid Association|October 10, 2019
A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid CancerAshish V Chintakuntlawar, Jun Yin, Robert L Foote, et al.
Cancers|January 23, 2024
Mean Oral Cavity Organ-at-Risk Dose Predicts Opioid Use and Hospitalization during Radiotherapy for Patients with Head and Neck TumorsRobert L Foote, W Scott Harmsen, Adam C Amundson, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2022
Detectable Postoperative Circulating Tumor Human Papillomavirus DNA and Association with Recurrence in Patients With HPV-Associated Oropharyngeal Squamous Cell CarcinomaDavid M Routman, Sunil Kumar, Bisham S Chera, et al.
Plos One|February 23, 2010
Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterationsBrian B Tuch, Rebecca R Laborde, Xing Xu, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2020
Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ Cancer of the OropharynxMark R Waddle, Daniel J Ma, Sue L Visscher, et al.
Oral Oncology|September 17, 2023
Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated diseaseKathleen R Bartemes, Benjamin R Gochanour, David M Routman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2019
Reply to A.S. GardenDaniel J Ma, Katharine A Price, Eric J Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2019
Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus-Associated Oropharynx Squamous Cell CarcinomaDaniel J Ma, Katharine A Price, Eric J Moore, et al.
Pageof 24